Publications by authors named "Maria Basagana-Torrento"
A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAP ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, Spain.
Teresa Garriga-Baraut Moises Labrador-Horrillo Mercé Tena Concepción De Linares Olga Esteso-Hontoria
Allergol Immunopathol (Madr)
July 2024
Article Synopsis
- Molecular diagnosis in allergology, particularly using the ImmunoCAP ISAC 112 microarray, improves identification of specific allergens in patients, enhancing the understanding of their allergies.
- A study conducted in Catalonia assessed this method's impact on diagnosis and treatment (specifically immunotherapy) in young patients with allergic conditions, showing significant shifts in treatment plans.
- Results indicated that over half of the patients (51%) had changes in their immunotherapy prescriptions based on molecular diagnostic findings, suggesting this approach leads to better-targeted treatments.
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease that is associated with severe uncontrolled eosinophilic asthma. Eosinophils play an important pathogenic role in the development of both diseases. Benralizumab is an antieosinophilic monoclonal antibody that binds to the α subunit of the human interleukin 5 receptor that is expressed on the surface of the eosinophil and basophil.
View Article and Find Full Text PDF